Aging-in-Place Fundraising: Active VCs & Medicare Playbook

How to raise venture capital for an aging-in-place, senior care, home health, or Medicare Advantage tech startup in 2026.

How to Raise Venture Capital for an Aging-in-Place / Senior Care Startup

Aging-in-place & senior care — Papa (Series D 2021 at ~$1.4B, layoffs + retrenchment 2023-2024), Honor (home care aggregator, Series E), Amazon Care shutdown 2022, Devoted Health ($12.6B valuation 2021, Medicare Advantage insurer), Alignment Healthcare (Nasdaq ALHC, MA insurer), Clover Health (Nasdaq CLOV, MA below IPO), Bright Health / NeueHealth (near-collapse 2023-2024), Cityblock Health (value-based care), Cadence (RPM for chronic care), Homeward Health (rural MA), Belong Health (D-SNP), plus MedArrive, DispatchHealth (in-home acute care, Series E), CareBridge (LTSS management, Anthem / Elevance acquisition 2024), plus dementia-specific (Rippl Care, Isaac Health, Uplift, Neuro Global) and caregiver-support (Wellthy, Rethink Care, ianacare) — spans Medicare Advantage insurers, home care aggregators, RPM devices, home health, dementia care under CMS GUIDE model, and family caregiver support.

Why aging-in-place is a distinct fundraising category

Senior care investors underwrite CMS + Medicare Advantage reimbursement complexity (V28 risk-adjustment model phase-in 2024-2026 cuts MA revenue $11B+ over three years, STAR ratings redesign, MA plan margin compression to sub-2% for many plans in 2024-2025), the CMS Innovation Center GUIDE model (Guiding an Improved Dementia Experience — launched July 2024, first-ever CMS payment model for dementia care coordination), the post-Papa retrenchment reality (Papa layoffs + Series D down-round exposure 2023-2024, Amazon Care shutdown 2022, Bright Health / NeueHealth near-collapse 2023-2024), and the Optum / CVS / Humana / Elevance / Cigna strategic-acquirer landscape (CVS / Signify $8B 2023, CVS / Oak Street $10.6B 2023, Optum / Amedisys $3.3B pending, Humana / Kindred, Elevance / CareBridge 2024).

The most active senior care VCs

Senior care + aging focused: Andreessen Horowitz Bio+Health (Devoted Health, Honor), General Catalyst (Devoted Health, Cadence, Homeward, Livongo pre-Teladoc), 7wireVentures (Livongo-founder Glen Tullman fund — Cityblock, Homeward, Transcarent), Town Hall Ventures (Andy Slavitt post-CMS — Cityblock, Waymark, Homeward, Belong Health), Frist Cressey Ventures (Bill Frist ex-Senator + HCA family), Oak HC/FT (Alignment, Wellthy, Devoted historic), Deerfield Management, F-Prime Capital, .406 Ventures, LRVHealth, Bessemer Venture Partners Healthcare, plus Primetime Partners (Abby Miller Levy — dedicated aging fund), Springbank Collective, Portfolia Aging + Longevity Fund.

Multi-stage generalists active in senior care: Sequoia (Devoted historic), Founders Fund, GV / Google Ventures (Flatiron adjacencies), Insight Partners, Coatue, Tiger Global (Cityblock peak), Kleiner Perkins, Redpoint, Menlo Ventures, Norwest, plus Goldman Sachs (Waymark), Fidelity + T. Rowe crossover (Devoted, Alignment).

Strategic capital + acquirers: UnitedHealth Group / Optum (largest MA + Medicare payer, acquired Amedisys $3.3B pending, LHC Group $5.4B 2023, Change Healthcare $13B 2022, DaVita Medical Group $4.9B 2019, Landmark Health 2021, naviHealth 2020), CVS Health / Aetna (acquired Signify Health $8B 2023, Oak Street Health $10.6B 2023, Aetna $69B 2018), Humana / CenterWell (largest MA-focused pure play, acquired Kindred at Home $8.1B 2021, ChoiceCare, One Homecare Solutions), Elevance / Anthem (acquired CareBridge 2024, myNexus 2021), Cigna / Evernorth (acquired Express Scripts $67B 2018, Bravo Wellness), Walgreens Boots Alliance / VillageMD ($5.2B 2021 + Summit Health $8.9B 2023 — troubled), Amazon Health (acquired One Medical $3.9B 2023, shut down Amazon Care 2022, PillPack $753M 2018), plus Kaiser Permanente, Molina Healthcare, Centene / WellCare.

CMS + Medicare Advantage reimbursement reality

V28 CMS-HCC risk-adjustment model phase-in 2024-2026 cuts MA revenue $11B+ over three years (removing ~2,000 diagnosis codes from risk-adjustment, reducing coding intensity). STAR ratings redesign (Tukey outlier deletion 2024, cut point calculations tightened) has cut STAR bonus payments across the industry. Combined effect: MA plan operating margins compressed to sub-2% for many plans in 2024-2025, several plans exited markets or reduced benefits.

MA enrollment continues to grow (50%+ of Medicare beneficiaries as of 2024), but plan economics have inverted — profitable enrollee growth requires actual care management + medical loss ratio discipline, not risk-adjustment coding intensity.

GUIDE model (Guiding an Improved Dementia Experience — CMS Innovation Center) launched July 2024. First-ever CMS payment model for dementia care coordination. 8-year model with ~400 participating organizations. Creates real revenue path for dementia-specific care (Rippl Care, Isaac Health, Uplift, Neuro Global positioned).

Post-Papa retrenchment + capital discipline

Papa Series D 2021 at ~$1.4B collapsed on unit economics + operational issues 2023-2024 (layoffs, retrenchment, down-round exposure). Amazon Care shutdown 2022 after failing to scale enterprise sales. Bright Health / NeueHealth near-collapse 2023-2024 (exited MA + individual markets, delisting from NYSE). Clover Health below IPO. Investors reset expectations: real Medicare Loss Ratio discipline (target 82-87%), 3-5 year LTV modeling with realistic enrollee churn (10-25% annual), positive contribution margin at plan-market level before scaling to new geographies, and named strategic-payer or provider integration path.

Common mistakes when raising for aging-in-place

Modeling MA plan economics on pre-V28 risk-adjustment intensity — investors immediately spot this. Ignoring STAR ratings redesign impact on bonus revenue. Not modeling GUIDE model participation for dementia-focused startups (July 2024 launch, 8-year model, first-of-kind CMS dementia payment model). Underestimating post-Papa / Bright Health retrenchment expectations. Positioning against UnitedHealth / Optum + CVS / Aetna vertically integrated stacks without a clear defensive moat or acqui-hire path. Ignoring the CVS / Signify $8B, CVS / Oak Street $10.6B, Optum / Amedisys $3.3B pending consolidation. Confusing home health (Medicare-covered, regulated) with home care (non-medical, private-pay or Medicaid HCBS). Not naming target CMS demonstration model (GUIDE, ACO REACH, Making Care Primary, Enhancing Oncology Model).

Frequently asked questions

Which are the most active senior care and aging-in-place VCs in 2026?
Senior-care-focused funds include Andreessen Horowitz Bio+Health (Devoted Health, Honor), General Catalyst (Devoted Health, Cadence, Homeward, Livongo pre-Teladoc), 7wireVentures (Livongo-founder Glen Tullman fund — Cityblock, Homeward, Transcarent), Town Hall Ventures (Andy Slavitt post-CMS — Cityblock, Waymark, Homeward, Belong Health), Frist Cressey Ventures (Bill Frist ex-Senator plus HCA family), Oak HC/FT (Alignment, Wellthy, Devoted historic), Deerfield Management, F-Prime Capital, .406 Ventures, LRVHealth, Bessemer Venture Partners Healthcare, Primetime Partners (Abby Miller Levy — dedicated aging fund), Springbank Collective, and Portfolia Aging + Longevity Fund. Generalists active in senior care include Sequoia (Devoted historic), Founders Fund, GV / Google Ventures, Insight Partners, Coatue, Tiger Global (Cityblock peak), Kleiner Perkins, Redpoint, Menlo Ventures, Norwest, Goldman Sachs (Waymark), and Fidelity plus T. Rowe crossover. Strategics include UnitedHealth / Optum, CVS / Aetna / Signify Health / Oak Street, Humana / CenterWell / Kindred at Home, Elevance / CareBridge, Cigna / Evernorth, Walgreens / VillageMD / Summit Health, Amazon Health / One Medical, Kaiser Permanente, Molina Healthcare, and Centene / WellCare.
How does the CMS V28 risk-adjustment model change Medicare Advantage economics?
V28 CMS-HCC risk-adjustment model phase-in 2024-2026 removes approximately 2,000 diagnosis codes from risk-adjustment and reduces coding intensity, cutting MA revenue $11B+ over three years. Combined with STAR ratings redesign (Tukey outlier deletion 2024, tightened cut point calculations), MA plan operating margins compressed to sub-2% for many plans in 2024-2025. Several plans exited markets or reduced benefits. MA enrollment continues to grow (50%+ of Medicare beneficiaries as of 2024), but plan economics have inverted — profitable enrollee growth now requires actual care management and medical loss ratio discipline (target 82-87%), not risk-adjustment coding intensity. Investors will not fund MA models built on pre-V28 coding intensity assumptions.
What is the GUIDE model and why does it matter for dementia care fundraising?
The Guiding an Improved Dementia Experience (GUIDE) model is a CMS Innovation Center payment model that launched July 1, 2024. It is the first-ever CMS payment model for dementia care coordination. The 8-year model has approximately 400 participating organizations providing comprehensive care coordination, caregiver support, and 24/7 access lines for beneficiaries with dementia. GUIDE creates a real revenue path for dementia-specific care startups (Rippl Care, Isaac Health, Uplift, Neuro Global are positioned in the space). Fundraising for dementia care in 2026 requires explicit GUIDE participation strategy or clear justification for a non-GUIDE payer path.
How did the Papa retrenchment and Bright Health near-collapse reset senior-care fundraising?
Papa raised a Series D in 2021 at approximately $1.4B valuation and collapsed on unit economics and operational issues in 2023-2024 with layoffs, retrenchment, and down-round exposure. Amazon Care shut down in 2022 after failing to scale enterprise sales. Bright Health / NeueHealth nearly collapsed in 2023-2024, exiting Medicare Advantage and individual markets and delisting from NYSE. Clover Health trades below IPO. Investors reset expectations to real medical loss ratio discipline (82-87% target), 3-5 year LTV modeling with realistic enrollee churn (10-25% annual), positive contribution margin at plan-market level before scaling to new geographies, and a named strategic-payer or provider integration path. Growth-at-all-costs senior-care narratives from 2020-2022 no longer meet the diligence bar.
Who are the strategic acquirers consolidating senior care?
UnitedHealth / Optum is the largest consolidator — Amedisys $3.3B (pending), LHC Group $5.4B (2023), Change Healthcare $13B (2022), DaVita Medical Group $4.9B (2019), Landmark Health (2021), naviHealth (2020). CVS Health / Aetna acquired Signify Health $8B (2023), Oak Street Health $10.6B (2023), and Aetna itself for $69B (2018). Humana / CenterWell is the largest MA-focused pure play and acquired Kindred at Home $8.1B (2021). Elevance / Anthem acquired CareBridge (2024) and myNexus (2021). Cigna / Evernorth acquired Express Scripts $67B (2018). Walgreens Boots Alliance / VillageMD ($5.2B in 2021 plus Summit Health $8.9B in 2023) has been troubled but is still active. Amazon Health acquired One Medical $3.9B (2023) and PillPack $753M (2018) but shut down Amazon Care in 2022. Kaiser Permanente, Molina Healthcare, and Centene / WellCare round out the strategic-payer set.

Related fundraising verticals (40)

Investor directory · Fundraising library · Articles A–Z · Company funding database